Загрузка...
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
PURPOSE: The independent predictive information from progesterone receptor (PgR) positivity for breast cancer treated with tamoxifen has been questioned after an overview by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). However, the studies in the overview were to a large content...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res Treat |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5065613/ https://ncbi.nlm.nih.gov/pubmed/27722840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-4007-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|